# The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics

> **NCT02142556** · PHASE3 · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 61 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Administration of quetiapine XR

## Key facts

- **NCT ID:** NCT02142556
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142556, "The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02142556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*